Team
Leadership
Prof. Moshe Shoham
Co-founder
Founder of Mazor Robotics Ltd. (acquired by Medtronic for $1.64 billion), and co-founder of multiple medtech companies. Prof. Shoham is a renowned figure in medical robotics and a member of the U.S. National Academy of Engineering.
Or Samoocha, M.Sc.
Co-founder
Electrical & Mechanical Engineer with 15 years’ experience in long-term implantable devices, expert in surface processing and multidisciplinary projects.
Dr. Igal Rasin
Dr. of Physics, with expertise in flow analysis and chemical/electrochemical processes.
Gadi Sicherman
Mechanical engineer and MBA with expertise in driving medical device projects into international markets.
Advisory Board
Prof. Tze Chuen Ng
Co-founder & Chairman of Advisory Board
Professor Emeritus at the University of Hong Kong. International consultant and inventor with over 30 years of experience in innovative developments ("outer space to inner space"). Winner of gold medals in international invention competitions, inventor and consultant for innovative medical and biological projects.
Prof. Raanan Berger
Prof. Raanan Berger, M.D., Ph.D., is Director of the Cancer Center at Sheba Medical Center, where he leads the clinical research facility and the genitourinary oncology programme. A senior oncologist and radiotherapist, he combines patient-centred care with pioneering research in prostate and breast cancer, and has authored more than 20 peer-reviewed scientific publications.
Prof. Chaya Brodie
A leading cancer biologist Emeritus Bar-Ilan University, with extensive experience in tumor progression and metastasis, advising on perioperative biology and translational study design.
Prof. Yuval Shaked
A leading cancer researcher and Professor at the Technion–Israel Institute of Technology, specializing in tumor microenvironment, metastasis, and therapy resistance, advising on perioperative metastatic risk and translational strategy.
Dr. Eyal Morag
An interventional radiologist with extensive experience in endovascular procedures, advising on intravascular device deployment, clinical workflow integration, and translational feasibility.
Prof. Gil Bar-Sela
Professor Gil Bar-Sela is a renowned professor of cancer, a specialist in supportive care for patients with cancer. A participant in international clinical trials, the main goal of which is to study the side effects of the treatment of oncological diseases. Professional experience over 20 years.